A Spinetti
University of Pisa
31 Papers
466 Citations
A Spinetti is an academic researcher from University of Pisa. The author has contributed to research in topics: Bone density & Osteoporosis. The author has an hindex of 18, co-authored 31 publications.
Chat about Author
Papers
Ultrasonographic bone characteristics during normal pregnancy : longitudinal and cross-sectional evaluation
TL;DR: During physiologic pregnancy the calcium mobilization from the maternal bone stores to accomplish the fetal needs can cause a significant decrease in maternal bone density in the last trimester of gestation.
74
The relative contributions of menopause and aging to postmenopausal vertebral osteopenia
Marco Gambacciani,A Spinetti,L. De Simone,Barbara Cappagli,Silvia Maffei,F. Taponeco,Piero Fioretti +6 more
TL;DR: The menopausal (hormonal) component of bone loss and a younger at the menopause represent the major factors in determining involutional vertebral osteopenia in women.
73
Menopause and the central nervous system: intervention options
TL;DR: The evidence suggests that hormone replacement therapy may reduce the relative risk of developing AD and the positive effects of estrogen on mood are probably related to its stimulatory action on adrenergic and serotoninergic tone.
67
Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women
Massimo Stomati,Beda Hartmann,A Spinetti,D Mailand,S Rubino,Alexander E. Albrecht,Johannes C. Huber,Felice Petraglia,Andrea R. Genazzani +8 more
TL;DR: Comparison of the effect of different HRT on plasma SHBG levels in relationship with the changes of plasma androgen, DHEAS, testosterone, androstenedione and insulin-like growth factor-1 levels concluded that plasma IGF-1 and androgen levels are not influenced from oral or transdermal HRT.
62
Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women
Marco Gambacciani,A Spinetti,Barbara Cappagli,F. Taponeco,R. Felipetto,Donatella Parrini,N. Cappelli,Piero Fioretti +7 more
TL;DR: It is demonstrated that ipriflavone administration prevents the rapid bone loss that follows ovariectomy in women and can represent an actractive alternative for the prevention of osteoporosis in postmenopausal women who present contraindications to the estrogen replacement therapy.
61